Received Mar 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | — |
sitting wait woman whose daughter is 28 and pregnant. Has HPV.; sitting wait woman whose daughter is 28 and pregnant. Has HPV.; This spontaneous prospective pregnancy report was received from a Consumer or other non-health professional and refers to a 28-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. The patient's gravidity was reported as 1 and information regarding her fetal outcome was not provided. On an unknown date, the patient was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) dose number 1 as prophylaxis (lot #, expiration date, dose, units, route of administration and anatomical location were not reported) (exposure during pregnancy). On an unknown date, the patient experienced human papillomavirus virus (HPV) infection (papilloma viral infection). By the reporting time, the patient had not recovered from the event papilloma viral infection, whereas regarding exposure during pregnancy was not provided. The causal relationship between the events and the suspect vaccine was not provided.